Isoniazid 异烟酰肼
CAS 54-85-3 MFCD00006426
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} A - K, Analytical Standards, Antibacterial, Antibiotics Standards, Antimycobacterial, Application Index, Cell Signaling Enzymes, Chemical Structure Class, Drug and Xenobiotic Metabolism, Multi-Drug Resistance and Drug Metabolism, Pharmaceuticals, Illicit Drugs & Alcohol, Pyridines and Pyrimidines, Spectrum of Activity, Substrates, Substrates, Inducers, Inhibitors, Wavelength Index, Xenobiotics and Drug Metabolism, 分析/色谱, 发光化合物及其检测, 抗生素, 生化试剂, 细胞信号转导和神经科学, 细胞生物学, 酶、抑制剂和底物
- {SNA} A - K,
- {SNA} Analytical Standards,
- {SNA} A - K,
产品应用
- 生化研究。高效液相色谱荧光检定∆4(4上标)-3甾酮类。制药工业。
相关文献及参考
- Short: III/20a
- Brewer, G.A., et al.: Anal. Profiles Drug Subs., 6, 183 (1977),
- Merck:14,5186
- Short: EINECS
- Short: III/5a
- Merck:14,5186 Beilstein:22(1)504
安全信息
GHS Symbol
- H302 Harmful if swallowed 吞食有害
- H315 Causes skin irritation 会刺激皮肤
- S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
- S36/37 Wear suitable protective clothing and gloves 穿戴适当的防护服和手套;
- S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
- S37 Wear suitable gloves 戴适当手套;
- S60 This material and its container must be disposed of as hazardous waste 该物质及其容器必须作为危险废物处置;
- R22 Harmful if swallowed 吞咽有害
- R38 Irritating to skin 刺激皮肤
- P201 Obtain special instructions before use. 使用前获取专门指示。
- P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
- P203
- P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
- P273 Avoid release to the environment. 避免释放到环境中。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P281 Use personal protective equipment as required. 使用所需的个人防护装备。
- P301+P312
- P301+P312+P330
- P301+P317
- P302+P352
- P305+P351+P338
- P305+P351+P338+P337+P313
- P307+P311
- P308+P311
- P308+P313
- P308+P316
- P314 Get medical advice/attention if you feel unwell. 获取医疗咨询/就医,如果你觉得不舒服
- P318
- P319
- P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
- P330 Rinse mouth. 漱口
- P332+P313
- P332+P317
- P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
- P362+P364
- P405 Store locked up. 上锁保管。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 15 gm/kg/30W-C TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors REFERENCE : GANNA2 Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. Volume(issue)/page/year: 51,83,1960
{haz
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 9 gm/kg/17W-I TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors REFERENCE : IJCNAW International Journal of Cancer. (International Union Against Cancer, 3 rue
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1892 mg/kg multigenerations TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Lungs, Thorax, or Respiration - tumors REFERENCE : JCROD7 Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- Volume(issue)/page/year: 105,258,1983
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1892 mg/kg multigenerations TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Lungs, Thorax, or Respiration - tumors REFERENCE : JCROD7 Journal of Cancer Resear
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intracerebral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : >12 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia REFERENCE : SZTPA5 Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. (Basel, Switzerland) V.1-18, 1944-61. Volume(issue)/page/year: 9,226,1952
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 255 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia REFERENCE : SZTPA5 Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. (Basel, Switzerland) V.1-18, 1944-61. Volume(issue)/page/year: 9,226,1952
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 1250 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 335 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia REFERENCE : SZTPA5 Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. (Basel, Switzerland) V.1-18, 1944-61. Volume(issue)/page/year: 9,226,1952
TYPE OF TEST
{hazard_co
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Bacteria - Salmonella typhimurium DOSE/DURATION : 1 mg/plate REFERENCE : CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 5,391,1984
TYPE OF TEST : Gene conversion and mitotic recombination TEST SYSTEM : Yeast - Saccharomyces cerevisiae DOSE/DURATION : 25 mmol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 91,215,1981
TYPE OF TEST : DNA repair TEST SYSTEM : Microorganism - not otherwise specified DOSE/DURATION : 7 mg/plate REFERENCE : BIZNAT Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- Volume(issue)/page/year: 95,4
TYPE OF TEST : Sister chromatid exchange TEST SYSTEM : Rodent - hamster Ovary DOSE/DURATION : 1 mmol/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 68,351,1979
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Microorganism - not otherwise specified DOSE/DURATION : 156 mg/L REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Vo
TYPE OF TEST : Body fluid assay TEST SYSTEM : Rodent - rat Bacteria - Salmonella typhimurium DOSE/DURATION : 90 mg/kg REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 56,289,1978
{
TYPE OF TEST :
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rabbit DOSE : 40 mg/kg SEX/DURATION : female 7-14 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) REFERENCE : DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-2
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE : 160 mg/kg SEX/DURATION : female 6-13 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : GJMSA7 Gunma Journal of Medical Sciences. (Maebashi, Japan) V.1-17, 1952-69. Discontinued. Volume(issue)/page/year: 14,233,1965
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE : 27900 ug/kg SEX/DURATION : female 6-14 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-24, 1966-72. For publisher information, see PJPPAA. Volume(issue)/page/year: 23,383,1971
其他信息
- 用途四:该品用作高效、低毒、价廉的抗结核病首选药物,也用作电镀添加剂和制药的中间体。导烟肼与甲醛亚硫酸氢钠缩合可制得异烟肼甲烷磺酸[13447-95-5]。与甲醛缩合成双异烟肼。这一缩合反应较溶易进行,将甲醛加入异烟肼水溶液,在65℃左右反应半小时即可。异烟肼与香草酸的缩合也在水溶液中进行,反应温度是95℃左右,生成异烟腙。这些异烟肼衍生物都是抗结核药物。异烟肼类以异烟肼的作用最好,异烟腙对结核菌的作用较异烟肼弱,但对神经系统及肝脏的毒性较异烟肼轻。
- 图谱信息:异烟肼(54-85-3)Raman光谱 异烟肼(54-85-3)核磁图( 1 HNMR) 异烟肼(54-85-3)质谱(MS) 异烟肼(54-85-3)红外图谱(IR2) 异烟肼(54-85-3)核磁图( 13 CNMR) 异烟肼(54-85-3)红外图谱(IR1)
- 方法二:由异烟酸与水合肼缩合而得。将异烟酸溶解于水合肼中,加入上批粗制母液,减压蒸馏至79-82℃(13.3-14.7kPa)为止。升温至129-130℃,反应3h。加入反应液一半量的母液稀释,加活性炭脱色,过滤。滤液冷却结晶,在10℃左右过滤,滤饼用粗制母液洗涤,得异烟肼粗品。然后经重结晶、活性炭脱色、过滤,干燥得成品。收率90%。
- 海关编码:29333999
- 用途一:主要用于各型肺结核,也可用于结核性脑膜炎和其他肺外结核等。常需和其他抗结核病药联用。
- TCI Shanghai:异烟肼 Isonicotinic Acid Hydrazide,>;98.0%(LC)(T)(54-85-3)
- Alfa Aesar:异烟肼,98+% Isonicotinic acid hydrazide, 98+%(54-85-3)
- 异烟肼价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 K5898001 异烟肼;异烟酰肼;雷米风;利抓哉;γ-吡啶甲酰肼 100g 356元 2011/08/23 KI337702 异烟肼;异烟酰肼;雷米风;利抓哉;γ-吡啶甲酰肼 50g 216元 2011/08/23 K5898002 异烟酰肼 500g 1167元
- Acros Organics:异烟酸肼 Isonicotinic acid hydrazide, 99%(54-85-3)
- 上游原料:高锰酸钾 --> 4-甲基吡啶 --> 异烟酸
- 用途三:生化研究,临床作为抗结核药物。
- 用途二:抗结核药,用于各种结核病
- 下游产品:4-异氰酸酯吡啶
- Sigma Aldrich:54-85-3(sigmaaldrich)
- 方法一:4-甲基吡啶经高锰酸钾氧化后,再与水合肼缩合制得。
- 无气味。味微甜而后苦。遇光渐变质。溶解度:25℃水约14%,40℃水约26%(水溶液呈中性),25℃乙醇约2%,沸乙醇约10%,氯仿约0.1%。几乎不溶于苯和乙醚。半数致死量(小鼠,腹腔)151mg/kg.
- 敏感性:Air Sensitive
- 参考质量标准:mp170-173℃,酸碱度合格,检测澄清度试验、重金属、干燥失重和灼烧残渣等杂质含量。
- MOL 文件:54-85-3.mol
- MSDS 信息:INAH(54-85-3).msds
- 用途五:生化研究。高效液相色谱荧光检定∆4(4上标)-3甾酮类。制药工业。